A recent meta-analysis by Schroeter et al. [3] revealed that S100B serum levels were consistently increased in acute major depressive or manic episodes, which was shown to be decreased after treatment with antidepressants, suggesting that S100B may be a biomarker for treatment outcomes in depression [14]. The gene discussed is S100B; the disease is major depressive disorder.